Do high glucose levels have differential effect on fdg uptake in inflammatory and malignant disorders?

Nuclear Medicine Communications

Volumn 22, Issue 10, 2001, Pages 1123-1128

  Zhuang, H M ^a   CortES Blanco A ^a   Pourdehnad, M ^a   Adam, L E ^a   Yamamoto, A J ^a   MartINEZ LAZARO R ^a   Lee, J H ^a   Loman, J C ^a   Rossman, M D ^a   Alavi, A ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

FDG; Hyperglycaemia; Inflammation; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE; GLUCOSE;

ARTICLE; BENIGN TUMOR; CONCENTRATION RESPONSE; DIET RESTRICTION; DRUG TUMOR LEVEL; DRUG UPTAKE; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IN VITRO STUDY; INFLAMMATION; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MESOTHELIOMA; MONONUCLEAR CELL; POSITRON EMISSION TOMOGRAPHY; TECHNIQUE;

BLOOD GLUCOSE; FLUORODEOXYGLUCOSE F18; HUMANS; INFLAMMATION; MESOTHELIOMA; MONOCYTES; NEOPLASMS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED; TUMOR CELLS, CULTURED;

EID: 0034748141     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200110000-00011     Document Type: Review

References (29)

1. Rigo P, Paulus P, Kaschten BJ, et al. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 1996; 23: 1641-1674.
2. Bar-Shalom R, Valdivia AY, Blaufox MD. PET imaging in oncology. Semin Nucl Med 2000; 30: 150-185.
3. Kubota R, Kubota K, Yamada S, et al. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J Nucl Med 1994; 35: 104-112.
4. Brudin LH, Valind SO, Rhodes CG, et al. Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur J Nucl Med 1994; 21: 297-305.
5. Lewis PJ, Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med 1994; 35: 1647-1649.
6. Guhlmann A, Brecht-Krauss D, Suger G, et al. Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings. Radiology 1998; 206: 749-754.
7. Sugawara Y, Braun D, Kison P, et al. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results. Eur J Nucl Med 1998; 25: 1238-1243.
8. Zhuang HM, Duarte PS, Pourdehand M, Shnier D, Alavi A. Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging. Clin Nucl Med 2000; 25: 281-284.
9. Zhuang HM, Duarte PS, Pourdehnad M, et al. The promising role of F-18-FDG PET in detecting infected lower limb prosthesis implants. J Nucl Med 2001; 42: 44-48.
10. Wahl RL, Henry CA, Ethier SP. Serum glucose - effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-d-glucose in rodents with mammary carcinoma. Radiology 1992; 183: 643-647.
11. Kay HD. A new procedure to overlay diluted blood on Ficoll-hypaque gradients. J Immunol Method 1980; 39: 81-83.
12. Smythe WR, Kaiser LR, Hwang HC, et al. Successful adenovirus-mediated gene-transfer in an in-vivo model of human-malignant mesothelioma. Ann Thorac Surg 1994; 57: 1395-1401.
13. Smith RJ, Hustinx R, Adam L-E, Karp JS. Clinical performance of the CPET camera [abstract]. J Nucl Med 1999; 40: 208.
14. Karp JS, Muehllehner G, Mankof FD, et al. Continuous-slice PENN-PET: a positron tomograph with volume imaging capability. J Nucl Med 1990; 31: 617-627.
15. Bedigian MP, Benard F, Smith RJ, Karp JS, Alavi A. Whole-body positron emission tomography for oncology imaging using singles transmission scanning with segmentation and ordered subsets expectation maximization (OS-EM) reconstruction. Eur J Nucl Med 1998; 25: 659-661.
16. Langen KJ, Braun U, Rota Kops E, et al. The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas. J Nucl Med 1993; 34: 355-359.
17. Lindholm P, Leskinen-Kallio S, Minn H, et al. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine in head and neck cancer. J Nucl Med 1993; 34: 1711-1716.
18. Diederichs CG, Staib L, Glatting G, Beger HG, Reske SN. FDG PET: Elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies. J Nucl Med 1998; 39: 1030-1033.
19. Maitra SR, Wojnar MM, Lang CH. Alterations in tissue glucose uptake during the hyperglycemic and hypoglycemic phases of sepsis. Shock 2000; 13: 379-385.
20. Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 1995; 36: 1301-1306.
21. Hansson L, Ohlsson T, Valind S, et al. Glucose utilisation in the lungs of septic rats. Eur J Nucl Med 1999; 26: 1340.
22. Weisdorf DJ, Craddock PR, Jacob HS. Granulocytes utilize different energy sources for movement and phagocytosis. Inflammation 1982; 6: 245-256.
23. Martin T, Losa JE, Garciasalgado MJ, Perezarellano JL. The role of platelet-activating-factor (Paf) in interstitial pulmonary disease. J Invest Allergol Clin Immunol 1994; 4: 149-157.
24. Yue TL, Rabinovici R, Feuerstein G. Platelet-activating factor (PAF) - a putative mediator in inflammatory tissue injury. Adv Exp Med Biol 1991; 314: 223-233.
25. Tetta C, Mariano F, Buades J, et al. Relevance of platelet-activating factor in inflammation and sepsis: Mechanisms and kinetics of removal in extracorporeal treatments. Am J Kidney Dis 1997; 30: S57-S65.
26. Lang CH, Dobrescu C, Hargrove DM, Bagby GJ, Spitzer JJ. Platelet-activating factor-induced increases in glucose kinetics. Am J Physiol 1988; 254: E193-E200.
27. Ottlakan A. Role of platelet-activating factor in glucose uptake and utilization of different tissues. Eur Surg Res 1998; 30: 393-402.
28. Torizuka T, Fisher SJ, Wahl RL. Insulin-induced hypoglycemia decreases uptake of 2-[F-18]-fluoro-2-deoxy-D-glucose to experimental mammary carcinoma. Radiology 1997; 203: 169-172.
29. Bushart GB, Vetter U, Hartmann W. Glucose transport during cell cycle in Im9 lymphocytes. Horm Metab Res 1993; 25: 210-213.